Intestinal O-GlcNAc signaling and mucosal host defense
肠道 O-GlcNAc 信号传导和粘膜宿主防御
基本信息
- 批准号:10444727
- 负责人:
- 金额:$ 48.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-23 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAllergicAllergic inflammationAnthelminticsAreaAutoimmune DiseasesCCL4 geneCell Differentiation processCellsChronicColitisCommunicable DiseasesDeveloped CountriesDevelopmentDiseaseEpithelialEpithelial CellsExposure toFutureGene FamilyGeneticGoalsGoblet CellsGranulomaHelminthsHost DefenseHost Defense MechanismHumanHygieneHyperplasiaImmuneImmune responseImmune systemImmunityIncidenceInfectionInflammationInflammatoryInflammatory Bowel DiseasesInterferon Type IIInterleukinsInterventionIntestinal MucosaIntestinal parasiteIntestinesKnockout MiceKnowledgeLaboratoriesLinkLymphoid CellMediatingMedicineModernizationModificationMucous MembraneMusO-GlcNAc transferaseOrganoidsParasitic infectionPathway interactionsPersonsPharmacologyPhysiologicalPhysiologyPlayPopulationPost-Translational Protein ProcessingPoverty AreasPreventiveProductionProteinsResearchRoleSTAT6 geneSerineSignal TransductionSocietiesSourceTSLP geneTestingTherapeuticTherapeutic EffectThreonineautoimmune inflammationcell typecitrate carriercytokineenteric infectionextracellulargenetic approachgut inflammationhelminth infectioninsightinterestintestinal epitheliumintestinal homeostasisnovelpathogenresponsetissue-repair responsestooltranscription factor
项目摘要
PROJECT SUMMARY
More than 1.5 billion people are infected with helminths worldwide, predominantly distributed in tropical and
subtropical areas. On the other hand, in developed countries with markedly reduced infectious diseases, there
is a continuing increase in the incidences of allergic, inflammatory, and autoimmune diseases. The hygiene
hypothesis proposes that an under-stimulated immune system resulting from the absence of exposure to
helminths, predisposes to autoimmune and allergic inflammation. There is an urgent need for new preventive
and therapeutic medicines for mucosal infection and inflammation. The research in my laboratory has been
focused on the pathophysiological role of O-linked N-Acetylglucosamine (O-GlcNAc) modification on intracellular
proteins at serine and threonine residues. The long-term goal is to elucidate the regulatory mechanisms and
physiological functions of O-GlcNAc signaling in intestinal homeostasis and mucosal host defense. In the
proposed study, we will test the hypothesis that O-GlcNAc transferase (OGT), by activating STAT6 signaling,
promotes the differentiation of IL-25-producing tuft cells and facilitates IL-33 secretion from goblet cells, thus
evoking type 2 immune responses for tissue repair and inflammation control. In Aim 1, we seek to define the
functional impact, upstream activating signals, and downstream targets of STAT6 O-GlcNAcylation in tuft cell
differentiation, type 2 immune activation, and helminth expulsion. In Aim 2, we identify a novel, common target
of OGT and STAT6 that colocalizes with IL-33 in goblet cells and mediates the unconventional secretion of IL-
33 to initiate type 2 immune responses. In Aim 3, using pharmacological and genetic approaches to increase
global protein O-GlcNAcylation in the intestinal epithelium, we expect to establish that the OGT-STAT6 pathway
is required for intestinal homeostasis and mediates the therapeutic effect of helminths in colitis. The proposed
study will provide valuable insights into the development of new intervention strategies to eradicate parasitic
worms in areas of poverty in the developing world and to treat inflammatory bowel disease in industrialized
countries.
项目摘要
超过15亿人感染了全球蠕虫,主要分布在热带和
亚热带地区。另一方面,在传染病明显降低的发达国家中
是过敏,炎症和自身免疫性疾病的发生率的持续增加。卫生
假设提出,由于缺乏暴露而导致的未刺激的免疫系统
蠕虫,易于自身免疫性和过敏性炎症。迫切需要新的预防性
以及用于粘膜感染和炎症的治疗药物。我的实验室的研究是
专注于O连接的N-乙酰葡萄糖(O-GLCNAC)在细胞内的病理生理作用
丝氨酸和苏氨酸残基的蛋白质。长期目标是阐明监管机制和
O-GLCNAC信号传导在肠内稳态和粘膜宿主防御中的生理功能。在
拟议的研究,我们将通过激活STAT6信号传导来检验O-GLCNAC转移酶(OGT)的假设
促进IL-25产生簇细胞的分化,并促进杯状细胞的IL-33分泌,从而
诱发2型免疫反应,用于组织修复和炎症控制。在AIM 1中,我们试图定义
功能影响,上游激活信号和簇状细胞中STAT6 O-Glcnacylation的下游目标
分化,2型免疫激活和蠕虫驱逐。在AIM 2中,我们确定了一个新颖的,共同的目标
在杯状细胞中与IL-33共定位的OGT和STAT6,并介导了IL-的非常规分泌
33启动2型免疫反应。在AIM 3中,使用药理学和遗传学方法来增加
全球蛋白质O-Glcnacylation在肠上皮中,我们希望确定OGT-STAT6途径
肠内稳态是必需的,并介导了结肠炎中蠕虫的治疗作用。提议
研究将为开发新干预策略的发展提供宝贵的见解,以消除寄生虫
发展中国家贫困地区的蠕虫,并治疗工业化的炎症性肠病
国家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hai-Bin Ruan其他文献
Hai-Bin Ruan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hai-Bin Ruan', 18)}}的其他基金
Intestinal O-GlcNAc signaling and mucosal host defense
肠道 O-GlcNAc 信号传导和粘膜宿主防御
- 批准号:
10578758 - 财政年份:2022
- 资助金额:
$ 48.84万 - 项目类别:
Protein O-GlcNAcylation in Regulatory T Cell Function
调节性 T 细胞功能中的蛋白 O-GlcNAc 酰化
- 批准号:
10284929 - 财政年份:2018
- 资助金额:
$ 48.84万 - 项目类别:
Protein O-GlcNAcylation in Regulatory T Cell Function
调节性 T 细胞功能中的蛋白 O-GlcNAc 酰化
- 批准号:
10054158 - 财政年份:2018
- 资助金额:
$ 48.84万 - 项目类别:
Protein O-GlcNAcylation in Regulatory T Cell Function
调节性 T 细胞功能中的蛋白 O-GlcNAc 酰化
- 批准号:
10509382 - 财政年份:2018
- 资助金额:
$ 48.84万 - 项目类别:
相似国自然基金
难治性过敏性鼻炎中更昔洛韦相关的特殊炎症机制及作用靶点探究
- 批准号:82371124
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IL-38调控嗜酸性粒细胞胞外诱捕网形成缓解过敏性哮喘气道炎症的机制研究
- 批准号:82302011
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CX3CR1+CD4+CTL细胞通过Nrf-2/NKG7介导上皮细胞毒性在过敏性哮喘气道炎症中的作用机制研究
- 批准号:82270034
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
DOCK2介导的TFH细胞在哮喘早期气道过敏性炎症中的作用及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
CD5L上调脂肪酸合成酶抑制ILC2减轻过敏性哮喘气道炎症的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Neuronal regulation of sinonasal Type 2 inflammation
鼻窦 2 型炎症的神经元调节
- 批准号:
10740468 - 财政年份:2023
- 资助金额:
$ 48.84万 - 项目类别:
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 48.84万 - 项目类别:
Molecular mechanisms of posttranscriptional gene regulation in asthmatic airway inflammation
哮喘气道炎症转录后基因调控的分子机制
- 批准号:
10698606 - 财政年份:2023
- 资助金额:
$ 48.84万 - 项目类别:
3-Dimensional genomic architecture in innate lymphoid cells and allergic inflammation
先天淋巴细胞和过敏性炎症的三维基因组结构
- 批准号:
10417585 - 财政年份:2022
- 资助金额:
$ 48.84万 - 项目类别: